| PRD_000758 | Name: | THIOPEPTIDE THIOSTREPTON REDUCED AT N-CA BOND OF RESIDUE 14 | Formula: | C72 H86 N19 O18 S5 | Description: | THIOSTREPTON IS A HETEROCYCLIC THIOPEPTIDE,
CONSISTING OF FOUR THIAZOLES, ONE THIOZOLINE,
ONE PIPERIDEINE RINGS.
A MODIFIED QUINOLINE, RESIDUE 0, IS LINKED TO
MAIN-CHAIN RESIDUE 1 AND SIDE-CHAIN OF RESIDUE 12.
IN THIS ENTRY RESIDUE 14 WAS CHEMICALLY MODIFIED TO
HAVE A SINGLE BOND N-CA. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000759 | Name: | THIOPEPTIDE THIOSTREPTON WITH EPIMER FORM OF RESIDUE 9 | Formula: | C69 H81 N18 O17 S5 | Description: | THIOSTREPTON IS A HETEROCYCLIC THIOPEPTIDE,
CONSISTING OF FOUR THIAZOLES ONE THIOZOLINE
ONE PIPERIDEINE RINGS.
A MODIFIED QUINOLINE, RESIDUE 0, IS LINKED TO
MAIN-CHAIN RESIDUE 1 AND SIDE-CHAIN OF RESIDUE 12.
IN THIS ENTRY RESIDUE 9 WAS CHEMICALLY MODIFIED
FROM D-CYS TO L-CYS AND RESIDUE 17 (HET DHA)
WAS DELETED. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_000760 | Name: | THIOPEPTIDE THIOSTREPTON OXIDIZED AT CA-CB BOND OF RESIDUE 9 | Formula: | C69 H79 N18 O17 S5 | Description: | THIOSTREPTON IS A HETEROCYCLIC THIOPEPTIDE,
CONSISTING OF FOUR THIAZOLES ONE THIOZOLINE
ONE PIPERIDEINE RINGS.
A MODIFIED QUINOLINE LINKED TO MAIN-CHAIN
RESIDUE 1 AND SIDE-CHAIN OF RESIDUE 12.
IN THIS ENTRY RESIDUE 9 WAS CHEMICALLY MODIFIED: THE
CA-CB BOND WAS OXIDIZED FROM SINGLE TO DOUBLE.
RESIDUE 17 (HET DHA) WAS DELETED. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
| PRD_002426 | Name: | Corramycin | Formula: | C51 H81 N11 O21 | Definition date: | 2023-08-16 | Last modified: | 2023-08-16 |
|
| PRD_002527 | Name: | Intermediate for maxamycins synthesis | Formula: | C84 H114 Cl2 N8 O17 S Si2 | Definition date: | 2023-07-05 | Last modified: | 2023-07-05 |
|
| PRD_001065 | Name: | teicoplanin | Formula: | C88 H97 Cl2 N9 O34 | Definition date: | 2013-05-29 | Last modified: | 2023-06-11 |
|
| PRD_002419 | Name: | Cyclomarin A | Formula: | C56 H82 N8 O11 | Definition date: | 2023-03-29 | Last modified: | 2023-03-29 |
|
| PRD_000468 | Name: | Allosamidin | Formula: | C25 H42 N4 O14 | Definition date: | 2015-07-18 | Last modified: | 2022-03-03 |
|
| PRD_000041 | Name: | (2S,3S,4R,5R,6R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3R,4R,5S)-4-(2-(3-AMINOPROPYLAMINO)ETHOXY)-5-((1R,2R,3S,5R,6S)-3,5-DIAM
INO-2-((2S,3R,4R,5S,6R)-3-AMINO-4,5-DIHYDROXY-6-(HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-6-HYDROXYCYCLOHEXYLOXY)-2-(
HYDROXYMETHYL)-TETRAHYDROFURAN-3-YLOXY)-TETRAHYDRO-2H-PYRAN-3,4-DIOL | Formula: | C28 H57 N7 O14 | Definition date: | 2017-07-12 | Last modified: | 2022-03-02 |
|
| PRD_000042 | Name: | (2S,3S,4R,5R,6R)-5-AMINO-2-(AMINOMETHYL)-6-((2R,3R,4R,5S)-5-((1R,2R,3S,5R,6S)-3,5-DIAMINO-2-((2S,3R,4R,5S,6R)-3-AMINO-4
,5-DIHYDROXY-6-(HYDROXYMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-6-HYDROXYCYCLOHEXYLOXY)-2-(HYDROXYMETHYL)-4-(2-((R)-PIPERIDI
N-3-YLMETHYLAMINO)ETHOXY)-TETRAHYDROFURAN-3-YLOXY)-TETRAHYDRO-2H-PYRAN-3,4-DIOL | Formula: | C31 H61 N7 O14 | Definition date: | 2017-07-12 | Last modified: | 2022-03-02 |
|
| PRD_000043 | Name: | DOUBLY FUNCTIONALIZED PAROMOMYCIN PM-II-162 | Formula: | C37 H65 N7 O16 | Definition date: | 2017-07-12 | Last modified: | 2022-03-02 |
|
| PRD_000204 | Name: | Vancomycin | Formula: | C66 H75 Cl2 N9 O24 | Description: | VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE, GLYCOSYLATED BY A DISACCHARIDE (RESIDUES 8 AND 9) ON RESIDUE 4. | Definition date: | 2012-12-12 | Last modified: | 2022-01-06 |
|
| PRD_002272 | Name: | (3R)-3,6-diamino-N-({(2R,5R,8Z,11S,15S)-15-amino-11-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-5-yl}methyl)hexanamide | Formula: | C25 H44 N14 O7 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
| PRD_002295 | Formula: | C89 H131 N23 O25 S3 | Definition date: | 2020-08-12 | Last modified: | 2020-08-12 |
|
| PRD_900080 | Name: | 2-deoxy-2-(trimethylammonio)-beta-D-glucopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->4)-2-(acety
lamino)-2-deoxy-beta-D-glucopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose | Formula: | C33 H59 N4 O20 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
| PRD_001136 | Name: | SUGAR (6-MER) | Formula: | C57 H82 O26 | Description: | Chromomycin A3 is an anthraquinone. It is a glycosidic antibiotic produced at the fermentation of a strain of Streptomyces griseus. It is also called toyomycin. | Definition date: | 2013-07-26 | Last modified: | 2020-04-04 |
|
| PRD_002368 | Name: | cyclo-Mle-Phe-Mle-D-Phe. D-Phe analogue of pseudoxylallemycin A | Formula: | C32 H44 N4 O4 | Definition date: | 2019-10-02 | Last modified: | 2019-10-02 |
|
| PRD_002333 | Name: | Pseudoxylallemycin A | Formula: | C32 H44 N4 O4 | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
| PRD_002334 | Name: | Linear tetrapeptide related to pseudoxylallemycin A | Formula: | C32 H46 N4 O5 | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
| PRD_002335 | Name: | Linear precursor of pseudoxylallemycin A | Formula: | C32 H46 N4 O5 | Description: | Mle-Phe-Mle-Phe. Linear precursor of pseudoxylallemycin A. The peptide is linear, unlike Mle-Phe-Mle-Phe Pseudoxylallemycin A that is cyclic. | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
| PRD_002306 | Name: | (2S,5R,8S,11S,14R,17S,20S,22R,23S)-5-[(2E)-but-2-en-1-yl]-23-hydroxy-8-({1-[(3R)-3-hydroxy-2-methylbutan-2-yl]-1H-indol-3-yl}methyl)-14-[(4-hydroxy-3-nitrophenyl)methyl]-10,17,19,22-tetramethyl-2,11-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazabicyclo[18.3.1]tetracosane-3,6,9,12,15,18,24-heptone | Formula: | C54 H77 N9 O12 | Definition date: | 2019-06-04 | Last modified: | 2019-06-04 |
|
| PRD_002331 | Name: | Chymostatin A (bound form) | Formula: | C31 H43 N7 O6 | Definition date: | 2018-10-24 | Last modified: | 2018-10-24 |
|
| PRD_001205 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S,3S)-2-hydroxy-5-methyl-1-oxo-1-(phenylamino)hexan-3-yl]-L-leucinamide | Formula: | C33 H48 N4 O6 | Definition date: | 2014-02-12 | Last modified: | 2017-09-14 |
|
| PRD_001206 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(3S)-5-methyl-1-(methylsulfonyl)hexan-3-yl]-L-leucinamide | Formula: | C28 H47 N3 O6 S | Definition date: | 2014-02-12 | Last modified: | 2017-09-14 |
|
| PRD_001207 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2R,3S)-1,2-dihydroxy-5-methylhexan-3-yl]-L-leucinamide | Formula: | C27 H45 N3 O6 | Definition date: | 2014-02-12 | Last modified: | 2017-09-14 |
|